Phibro Animal Health Corp

Phibro Animal Health Corp. announces a quarterly dividend, signaling strong cash flow and confidence in its diversified vaccine portfolio and long‑term growth prospects.

Phibro Animal Health (PHA) leads the animal health & mineral nutrition sector with a diversified product line and steady growth, offering investors a resilient, innovative market presence.

Phibro Animal Health Corp reported a strong Q4 earnings beat, with a 39% revenue increase and $0.57 EPS, sending its stock soaring 18% in after-hours trading.